Therapeutic effect of Fosfomycin (FOM) on bacillary dysentery and resembling infections was studied, and antimicrobial activities of FOM and other antibiotics to 126 strains of Shigella, 79 of Salmonella and 5 of Vibrio parahaemolyticus that were isolated from the patients were determined. The results obtained are summarized below.
1) Shigella, Salmonella, and Vibrio parahaemolyticus strains were inhibited at below 50 μg/ml of FOM. In most strains other than Shigella frexneri, relatively high MIC values were obtained (12.5μ, g ml in Shigella sonnei, 3.12 μg/ml in Salmonella, and 25 μg/ml in Vibrio parahaemolyticus).
2) FOM produced excellent results in both bacteriological and clinical studies especially in bacillary dysentery. A very high efficacy rate of 97.5% in bacterial elimination was obtained.
3) In Salmonella enteritis, FOM did not necessarily showed favorable results (67.8%) in bacterial elimination, . However, when compared from all viewpoints including clinical effects, FOM can not be regarded at all as inferior to any other drugs now available for this disease.
4) Slight side-effects were observed in 10.7% of the cases, and there was only one case in which administration of the drug was discontinued. Persistent soft stool observed in 9.4% of patients was normalized soon after discontinuance of the drug.
This study was conducted on the patients and carriers of above mentioned diseases who were hospitalized in 10 municipal infectious disease hospitals, and drug sensitivity test was made at Tokyo Metropolitan Institute of Health. Co-workers in this study are listed below.
View full abstract